\r\n<\/a>\r\n<\/p>\n<\/div><\/section><\/div> <\/p>\n<\/div><\/section> <\/p>\n In 2016 ELITechGroup introduced ELITe InGenius, its first sample-to-result system for molecular diagnostics. Since then, the company has been expanding the system\u2019s menu to more than 50 CE-IVD parameters and has validated more than 20 sample matrices. BeGenius was launched in 2021 to address the needs of laboratories that require higher throughput.<\/p>\n To date, more than 1100 InGenius and BeGenius instruments have been installed across the globe. Users appreciate the broad menu as well as the instrument\u2019s versatility and robustness.<\/p>\n Elitech MDx is transitioning its complete portfolio of CE-IVD parameters to IVDR and has already received the first IVDR certificates for both InGenius and BeGenius.<\/p>\n The company\u2019s new high throughput system will be based on ELITech\u2019s proven extraction and assay technology. It will use the same reagents as InGenius and BeGenius. The instru- ELITech\u2019s broad and expanding menu of IVD assays together with the instrument\u2019s superior throughput and multiplexing capability will make it the ideal platform for laboratories with a high level of complexity in their routine testing.<\/p>\n The European launch of the new system is planned for the end of 2024.<\/p>\n<\/div><\/section> <\/p>\n<\/div><\/section><\/div>\n","protected":false},"excerpt":{"rendered":" ELITech showcases new high throughput sample-to-result instrument for molecular diagnostics Also at ECCMID, ELITech Group unveiled the upcoming launch of a new high throughput sample-to-result instrument for molecular diagnostics.<\/p>\n","protected":false},"author":3,"featured_media":19516,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[52],"tags":[],"class_list":["post-19515","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured-articles"],"_links":{"self":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/19515"}],"collection":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/comments?post=19515"}],"version-history":[{"count":4,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/19515\/revisions"}],"predecessor-version":[{"id":19521,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/posts\/19515\/revisions\/19521"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media\/19516"}],"wp:attachment":[{"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/media?parent=19515"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/categories?post=19515"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/clinlabint.com\/wp-json\/wp\/v2\/tags?post=19515"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nELITech showcases new high throughput sample-to-result instrument for molecular diagnostics<\/h1>\/ in Featured Articles<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n
\nELITech showcases new high throughput sample-to-result instrument for molecular diagnostics<\/h4>\n
Also at ECCMID, ELITech Group unveiled the upcoming launch of a new high throughput sample-to-result instrument for molecular diagnostics.<\/h3>\n
\nment offers continuous loading of samples and reagents coupled with real random-access capability. The user will be able to run in parallel different PCR reagents, protocols, and sample matrices, with maximum versatility.<\/p>\n
\n
\nShare this<\/h5>